ATE425745T1 - Medikament auf der basis von ein antihyperglykamikum enthaltenden mikrokapseln mit gesteuerter freisetzung - Google Patents
Medikament auf der basis von ein antihyperglykamikum enthaltenden mikrokapseln mit gesteuerter freisetzungInfo
- Publication number
- ATE425745T1 ATE425745T1 AT01996365T AT01996365T ATE425745T1 AT E425745 T1 ATE425745 T1 AT E425745T1 AT 01996365 T AT01996365 T AT 01996365T AT 01996365 T AT01996365 T AT 01996365T AT E425745 T1 ATE425745 T1 AT E425745T1
- Authority
- AT
- Austria
- Prior art keywords
- hyperglycaemic
- medicine
- microcapsules
- antihyperglycamic
- metformin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0014876A FR2816840B1 (fr) | 2000-11-17 | 2000-11-17 | Medicament a base de microcapsules d'anti-hyperclycemiant a liberation prolongee et son procede de preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE425745T1 true ATE425745T1 (de) | 2009-04-15 |
Family
ID=8856604
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01996365T ATE425745T1 (de) | 2000-11-17 | 2001-11-19 | Medikament auf der basis von ein antihyperglykamikum enthaltenden mikrokapseln mit gesteuerter freisetzung |
Country Status (13)
Country | Link |
---|---|
US (1) | US8197850B2 (de) |
EP (1) | EP1333816B1 (de) |
JP (1) | JP2004513913A (de) |
CN (2) | CN1853617A (de) |
AT (1) | ATE425745T1 (de) |
AU (1) | AU2002220796A1 (de) |
BR (1) | BR0115958A (de) |
CA (1) | CA2428782C (de) |
DE (1) | DE60138033D1 (de) |
ES (1) | ES2324205T3 (de) |
FR (1) | FR2816840B1 (de) |
PT (1) | PT1333816E (de) |
WO (1) | WO2002039984A2 (de) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2822834B1 (fr) * | 2001-04-02 | 2005-02-25 | Flamel Tech Sa | Suspension colloidale de nanoparticules a base de copolymeres amphiphile pour la vectorisation de principes actifs et leur mode de preparation |
FR2825023B1 (fr) * | 2001-05-23 | 2005-04-15 | Flamel Tech Sa | Forme pharmaceutique orale antidiabetique "une prise par jour"comprenant une biguanide et au moins un autre principe actif |
US8101209B2 (en) | 2001-10-09 | 2012-01-24 | Flamel Technologies | Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
FR2837100B1 (fr) * | 2002-03-18 | 2004-07-23 | Flamel Tech Sa | Comprimes a bases de microcapsules a liberation modifiee |
EP1492511B3 (de) | 2002-04-09 | 2012-05-02 | Flamel Technologies | Orale wässrige suspension, mikrokapseln enthaltend, zur kontrollierten freisetzung von wirkstoffen |
CN100577164C (zh) | 2002-04-09 | 2010-01-06 | 弗拉梅技术公司 | 可改进释放阿莫西林的微囊含水混悬液形式的口服药物制剂 |
FR2843881B1 (fr) * | 2002-09-02 | 2006-06-02 | Flamel Tech Sa | Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee de principe(s) actif(s) |
FR2842736B1 (fr) | 2002-07-26 | 2005-07-22 | Flamel Tech Sa | Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s) |
FR2842735B1 (fr) * | 2002-07-26 | 2006-01-06 | Flamel Tech Sa | Microcapsules a liberation modifiee de principes actifs peu solubles pour l'administration per os |
FR2843117B1 (fr) * | 2002-07-30 | 2004-10-15 | Flamel Tech Sa | Polyaminoacides fonctionnalises par au moins un groupement hydrophobe et leurs applications notamment therapeutiques |
ES2355233T3 (es) * | 2002-09-28 | 2011-03-24 | Mcneil-Ppc, Inc. | Formas de dosificación de liberación modificada con dos núcleos y una abertura. |
EP1510208A1 (de) * | 2003-08-22 | 2005-03-02 | Fournier Laboratories Ireland Limited | Metformin-Statin-Kombination enthaltende pharmazeutische Zusammensetzungen |
FR2860516B1 (fr) * | 2003-10-03 | 2006-01-13 | Flamel Tech Sa | Homopolyaminoacides telecheliques fonctionnalises par des groupements hydrophobes et leurs applications notamment therapeutiques |
FR2862536B1 (fr) * | 2003-11-21 | 2007-11-23 | Flamel Tech Sa | Formulations pharmaceutiques pour la liberation prolongee de principe(s) actif(s), ainsi que leurs applications notamment therapeutiques |
NZ550171A (en) | 2004-03-02 | 2009-05-31 | Poly Coat Pty Ltd | A multi-component paintable primer system incorporating a thermoplastic cellulose polymer |
EP1591114A1 (de) * | 2004-03-12 | 2005-11-02 | Fournier Laboratories Ireland Limited | Verwendung von Metformin und Orlistat zur Behandlung oder Vorbeugung von Obesität |
CN101602865B (zh) * | 2009-03-13 | 2011-08-31 | 王懋 | 一种乙基纤维素混悬液及其制备方法与应用 |
AU2011224350B2 (en) * | 2010-03-09 | 2015-07-02 | Alkermes Pharma Ireland Limited | Alcohol resistant enteric pharmaceutical compositions |
US8581001B2 (en) | 2010-04-16 | 2013-11-12 | Codman & Shurtleff | Metformin-cysteine prodrug |
WO2013077821A1 (en) * | 2011-11-23 | 2013-05-30 | Mahmut Bilgic | Homogeneous biguanide composition |
CN103637999B (zh) * | 2013-12-12 | 2014-12-03 | 南通联亚药业有限公司 | 一种多层固体药物剂型 |
US9962336B2 (en) | 2014-05-01 | 2018-05-08 | Sun Pharmaceutical Industries Limited | Extended release suspension compositions |
US20180104197A9 (en) | 2014-05-01 | 2018-04-19 | Sun Pharmaceutical Industries Limited | Extended release liquid compositions of metformin |
WO2016016845A1 (en) | 2014-07-30 | 2016-02-04 | Sun Pharmaceutical Industries Limited | Dual-chamber pack |
US10258583B2 (en) | 2014-05-01 | 2019-04-16 | Sun Pharmaceutical Industries Limited | Extended release liquid compositions of guanfacine |
WO2015166473A1 (en) | 2014-05-01 | 2015-11-05 | Sun Pharmaceutical Industries Limited | Extended release suspension compositions |
EP3288539A4 (de) * | 2015-05-01 | 2019-07-10 | Sun Pharmaceutical Industries Ltd | Flüssige retard-zusammensetzungen von metformin |
US10369078B2 (en) | 2016-05-02 | 2019-08-06 | Sun Pharmaceutical Industries Limited | Dual-chamber pack for pharmaceutical compositions |
US10238803B2 (en) | 2016-05-02 | 2019-03-26 | Sun Pharmaceutical Industries Limited | Drug delivery device for pharmaceutical compositions |
FR3055800B1 (fr) * | 2016-09-15 | 2020-06-26 | Unither Pharmaceuticals | Composition solide a ingestion rapide et deglutition facilitee, sous forme de particules solides non agglomerees, comprenant deux differents types de particules |
AU2019232145A1 (en) * | 2018-03-07 | 2020-10-01 | Teagasc - The Agriculture And Food Development Authority | A composition for type II diabetics and for use in providing sustained energy release over time |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO154918C (no) | 1977-08-27 | 1987-01-14 | Bayer Ag | Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin. |
JPS6051189A (ja) | 1983-08-30 | 1985-03-22 | Sankyo Co Ltd | チアゾリジン誘導体およびその製造法 |
DE3543999A1 (de) | 1985-12-13 | 1987-06-19 | Bayer Ag | Hochreine acarbose |
GB9104854D0 (en) * | 1991-03-07 | 1991-04-17 | Reckitt & Colmann Prod Ltd | Sustained release compositions |
ATE154241T1 (de) * | 1991-10-01 | 1997-06-15 | Takeda Chemical Industries Ltd | Mikropartikeln-zusammenfassung zur verlängerten freigabe und herstellung derselbe |
JP3277342B2 (ja) * | 1992-09-02 | 2002-04-22 | 武田薬品工業株式会社 | 徐放性マイクロカプセルの製造法 |
US5594016A (en) | 1992-12-28 | 1997-01-14 | Mitsubishi Chemical Corporation | Naphthalene derivatives |
JPH08151322A (ja) * | 1994-09-30 | 1996-06-11 | Takeda Chem Ind Ltd | 経口徐放剤 |
FR2725623A1 (fr) * | 1994-10-18 | 1996-04-19 | Flamel Tech Sa | Microcapsules medicamenteuses et/ou nutritionnelles pour administration per os |
IT1276130B1 (it) | 1995-11-14 | 1997-10-27 | Gentili Ist Spa | Associazione glibenclamide-metformina, composizioni farmaceutiche che la contengono e loro uso nel trattamento del diabete mellito di tipo |
US20030064108A1 (en) | 1996-04-23 | 2003-04-03 | Stefan Lukas | Taste masked pharmaceutical compositions |
AU729529B2 (en) | 1997-06-06 | 2001-02-01 | Depomed, Inc. | Gastric-retentive oral drug dosage forms for controlled release of highly soluble drugs |
EA003101B1 (ru) * | 1998-03-19 | 2002-12-26 | Бристол-Майерз Сквибб Компани | Двухфазная система доставки с регулируемым высвобождением для фармацевтических средств с высокой растворимостью и способ лечения диабета с помощью этой системы |
US6099859A (en) | 1998-03-20 | 2000-08-08 | Andrx Pharmaceuticals, Inc. | Controlled release oral tablet having a unitary core |
ATE250418T1 (de) | 1998-07-15 | 2003-10-15 | Merck Sante Sas | Tabletten enthaltend eine kombination von glibenclamid und metformin |
US6099862A (en) | 1998-08-31 | 2000-08-08 | Andrx Corporation | Oral dosage form for the controlled release of a biguanide and sulfonylurea |
JP2000085159A (ja) | 1998-09-14 | 2000-03-28 | Ricoh Co Ltd | 画像処理方法 |
BR9915285A (pt) * | 1998-11-12 | 2001-08-07 | Smithkline Beecham Plc | Composição farmacêutica para liberação modificada de um sensitivador de insulina e um outro agente antidiabético |
DE19860698A1 (de) | 1998-12-30 | 2000-07-06 | Hexal Ag | Neue pharmazeutische Zusammensetzung |
US7576131B2 (en) | 1999-06-04 | 2009-08-18 | Metabolex, Inc. | Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
US6428809B1 (en) | 1999-08-18 | 2002-08-06 | Microdose Technologies, Inc. | Metering and packaging of controlled release medication |
CO5200844A1 (es) | 1999-09-17 | 2002-09-27 | Novartis Ag | Una combinacion que comprende nateglinida y cuando por menos otro compuesto antidiabetico usada para el tratamiento de desordenes metabolicos, especialmente diabetes, o de una enfermedad o condicion asociada con dibetes |
HU229352B1 (en) | 1999-11-03 | 2013-11-28 | Bristol Myers Squibb Co | Medicament comprising the combination of metformin and glyburide |
US6586438B2 (en) | 1999-11-03 | 2003-07-01 | Bristol-Myers Squibb Co. | Antidiabetic formulation and method |
KR20020063282A (ko) * | 1999-12-28 | 2002-08-01 | 아지노모토 가부시키가이샤 | 경구 투여용 당뇨병 치료제 |
FR2811571B1 (fr) * | 2000-07-11 | 2002-10-11 | Flamel Tech Sa | Composition pharmaceutique orale, permettant la liberation controlee et l'absorption prolongee d'un principe actif |
FR2825023B1 (fr) | 2001-05-23 | 2005-04-15 | Flamel Tech Sa | Forme pharmaceutique orale antidiabetique "une prise par jour"comprenant une biguanide et au moins un autre principe actif |
-
2000
- 2000-11-17 FR FR0014876A patent/FR2816840B1/fr not_active Expired - Fee Related
-
2001
- 2001-11-19 WO PCT/FR2001/003625 patent/WO2002039984A2/fr active Application Filing
- 2001-11-19 AU AU2002220796A patent/AU2002220796A1/en not_active Abandoned
- 2001-11-19 CN CNA2006100577550A patent/CN1853617A/zh active Pending
- 2001-11-19 JP JP2002542359A patent/JP2004513913A/ja active Pending
- 2001-11-19 US US10/415,850 patent/US8197850B2/en not_active Expired - Fee Related
- 2001-11-19 CA CA2428782A patent/CA2428782C/fr not_active Expired - Fee Related
- 2001-11-19 PT PT01996365T patent/PT1333816E/pt unknown
- 2001-11-19 BR BR0115958-5A patent/BR0115958A/pt not_active Application Discontinuation
- 2001-11-19 ES ES01996365T patent/ES2324205T3/es not_active Expired - Lifetime
- 2001-11-19 AT AT01996365T patent/ATE425745T1/de active
- 2001-11-19 CN CNA018190421A patent/CN1474687A/zh active Pending
- 2001-11-19 EP EP01996365A patent/EP1333816B1/de not_active Expired - Lifetime
- 2001-11-19 DE DE60138033T patent/DE60138033D1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU2002220796A1 (en) | 2002-05-27 |
DE60138033D1 (de) | 2009-04-30 |
PT1333816E (pt) | 2009-06-23 |
BR0115958A (pt) | 2004-01-06 |
JP2004513913A (ja) | 2004-05-13 |
EP1333816A2 (de) | 2003-08-13 |
ES2324205T3 (es) | 2009-08-03 |
CN1853617A (zh) | 2006-11-01 |
WO2002039984A3 (fr) | 2002-07-11 |
CN1474687A (zh) | 2004-02-11 |
US20040175424A1 (en) | 2004-09-09 |
FR2816840A1 (fr) | 2002-05-24 |
CA2428782A1 (fr) | 2002-05-23 |
CA2428782C (fr) | 2013-01-08 |
EP1333816B1 (de) | 2009-03-18 |
WO2002039984A2 (fr) | 2002-05-23 |
FR2816840B1 (fr) | 2004-04-09 |
US8197850B2 (en) | 2012-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE425745T1 (de) | Medikament auf der basis von ein antihyperglykamikum enthaltenden mikrokapseln mit gesteuerter freisetzung | |
CA2130464C (en) | Topical aromatic releasing compositions | |
Sajan et al. | Chronotherapeutics and chronotherapeutic drug delivery systems | |
Ahad et al. | Transdermal delivery of antidiabetic drugs: formulation and delivery strategies | |
Tripathi | Essentials of pharmacology for dentistry | |
ATE48598T1 (de) | Gewisse 3-(5-aminopentyl)-amino-1-benzazepin-2-on-1-alk nsaeuren, verfahren zu ihrer herstellung, pharmazeutische praeparate enthaltend diese verbindungen, sowie ihre therapeutische verwendung. | |
CN102143687A (zh) | 4-氨基吡啶在改善具有脱髓鞘和其它神经***状况的患者的神经-认知和/或神经-精神病学损伤中的用途 | |
DE3814532A1 (de) | Dhp-retard-zubereitung | |
Tönder et al. | Sulfonamide-induced chronic liver disease | |
Shukla et al. | Transdermal delivery via medical device technologies | |
DE69530673T2 (de) | Verhütung oder Verminderung von Photosensitivität oder phototoxischen Reaktionen auf antiinfektiöse Medikamente | |
Jackson et al. | Another abusable amphetamine | |
Hitselberger et al. | Photosensitivity due to chlorpropamide | |
DE69008107D1 (de) | Zubereitung mit verzögerter Freigabe eines Hydrochlorids eines basischen Arzneistoffs. | |
De Haen | The drug lag—Does it exist in Europe? | |
DE69516706D1 (de) | Bis-2-aminopyridine, verfahren zu ihrer herstelung und ihre verwendung zur bekämpfung von parasitosen | |
JPH0327313A (ja) | 生理的用量のビタミンaと治療活性のある各種有効成分とを有する組成物 | |
Heilmann | Innovations in drug delivery systems | |
Mir et al. | Epilepsy and Neuroinflammation: Unraveling the Complex Connection | |
Townsend et al. | Continuing rise in emergency admissions. Visiting elderly patients at home immediately after discharge reduces emergency readmissions. | |
Torrens et al. | Parotid swelling and terbinafine. | |
Alván et al. | The validity of the sigmoid Emax model and efficiency concept in diuretic studies. | |
Suresh et al. | Oral film technology: a perspective on translational research and clinical studies | |
SU980720A1 (ru) | Способ лечени больных лепрой | |
DE60013638T2 (de) | Oral verabreichbares pharmazeutisches Produkt und Verfahren zu seiner Herstellung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1333816 Country of ref document: EP |